Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TNF Pharmaceuticals Inc TNFA

TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a... see more

NDAQ:TNFA - Post Discussion

TNF Pharmaceuticals Inc > Up another 27% today
View:
Post by GripnRip on Jan 31, 2023 3:29pm

Up another 27% today

Ogo - anything you would care to share about this Co"?

Can PM me
Comment by Ogopogo007 on Jan 31, 2023 9:29pm
Sorry can't, investment advice I pay for. However SP tells you things are going quite well If they can replicate in humans what they did in mice....will be a multi, multi bagger.
Comment by GripnRip on Feb 01, 2023 7:58am
shucks, I was only hoping for a multi bagger not a multi, multi bagger Certainly the ability to reduce inflamation as one ages is the Holy Grail in reducing diseases, aging process. Believe they are involved in Ph 2 trial - muscle wasting, was wondering if recent pop in SP was related to news there? TNF-alpha taming news?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities